However, we observed that the levels of EIF4G1 expression were closely correlated with the T classification (T1-T2 vs. T3-T4) (P = 0.039), lymph node involvement (N classification, N0-N1 vs. N2-N3) (P = 0.008), and clinical stage (I-II vs. III-IV) (P = 0.003) in NPC patients. This evidence concerns the gene EIF4G1 and nasopharyngeal carcinoma.